Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2011
Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors
David E Gerber, Alison T Stopeck, Lucas Wong, et al.
Breast Cancer Research and Treatment
|
September 16, 2022
Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment
Folnetti A Alvarez, Hussein Kaddour, Yuan Lyu, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
August 31, 2002
Radial fast spin-echo method for T2-weighted imaging and T2 mapping of the liver
Maria I Altbach, Eric K Outwater, Theodore P Trouard, et al.
Clinical & Experimental Metastasis
|
June 14, 2012
The role of targeted therapy and biomarkers in breast cancer treatment
Alison T Stopeck, Ursa Brown-Glaberman, Hong Yuen Wong, et al.
Blood
|
June 27, 2012
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2015
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease
Ingo J Diel, Jean-Jacques Body, Alison T Stopeck, et al.
Leukemia & Lymphoma
|
April 18, 2009
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
Breast Cancer Research and Treatment
|
January 18, 2022
Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer
Jessica A Martinez, Betsy C Wertheim, Denise J Roe, et al.
Magnetic Resonance Imaging
|
February 8, 2025
Concurrent water T<sub>2</sub> and fat fraction mapping of the breast using the radial gradient and spin echo (RADGRASE) pulse sequence
Tomoe Hagio, Jean-Philippe Galons, Denise Roe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Allan Lipton, Matthew R Smith, Karim Fizazi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2011
Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors
David E Gerber, Alison T Stopeck, Lucas Wong, et al.
Breast Cancer Research and Treatment
|
September 16, 2022
Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment
Folnetti A Alvarez, Hussein Kaddour, Yuan Lyu, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
August 31, 2002
Radial fast spin-echo method for T2-weighted imaging and T2 mapping of the liver
Maria I Altbach, Eric K Outwater, Theodore P Trouard, et al.
Clinical & Experimental Metastasis
|
June 14, 2012
The role of targeted therapy and biomarkers in breast cancer treatment
Alison T Stopeck, Ursa Brown-Glaberman, Hong Yuen Wong, et al.
Blood
|
June 27, 2012
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2015
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease
Ingo J Diel, Jean-Jacques Body, Alison T Stopeck, et al.
Leukemia & Lymphoma
|
April 18, 2009
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
Breast Cancer Research and Treatment
|
January 18, 2022
Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer
Jessica A Martinez, Betsy C Wertheim, Denise J Roe, et al.
Magnetic Resonance Imaging
|
February 8, 2025
Concurrent water T<sub>2</sub> and fat fraction mapping of the breast using the radial gradient and spin echo (RADGRASE) pulse sequence
Tomoe Hagio, Jean-Philippe Galons, Denise Roe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Allan Lipton, Matthew R Smith, Karim Fizazi, et al.
Page
of 5